Results 111 to 120 of about 16,979 (251)

Editorial: Management of borderline ovarian tumor: The best treatment is a real challenge in the era of precision medicine. [PDF]

Front Surg, 2023
Della Corte L, Cafasso V, Mercorio A, Vizzielli G, Conte C, Giampaolino P.   +5 more
europepmc   +1 more source

[Ovarian cancer and borderline tumors].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1998
Long-term trends in the incidence, prognosis, and mortality of patients with ovarian cancer and borderline tumours in Norway were examined based on data from the population-based Cancer Registry of Norway. The incidence of ovarian cancer rose continuously from the mid-1950s to the mid-1980s.
T, Bjørge, A, Engeland, S, Hansen, C G, Tropé   +3 more
openaire   +1 more source

Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity

VIEW, EarlyView.
Cancer cells are vulnerable to oxidative stress, yet exploit immune tolerance to escape destruction. In contrast, their metabolic profile is markedly altered to support rapid proliferation, accompanied by elevated production of reactive oxygen species (ROS).
Manuela Calin, Galyna Bila, Ileana Manduteanu, Rostyslav Bilyy   +3 more
wiley   +1 more source

Appendiceal mucocele masquerading as an epithelial borderline ovarian tumor: a case report and literature review. [PDF]

Korean J Clin Oncol, 2022
Kim YJ, Yun JH, Hong SH, Song G, Lee JE, Son MW, Han SW, Kim SY, Lee MS.   +8 more
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis. [PDF]

Healthcare (Basel), 2023
Pecorino B, Laganà AS, Mereu L, Ferrara M, Carrara G, Etrusco A, Di Donna MC, Chiantera V, Cucinella G, Barra F, Török P, Scollo P.   +11 more
europepmc   +1 more source

Small Bowel Cancer: Implications of Preoperative Work‐Up on Surgical Strategy

World Journal of Surgery, EarlyView.
Small bowel cancers comprise a heterogeneous group of malignancies, making diagnosis and treatment challenging. This study aimed to evaluate the ability of preoperative diagnostic work‐up to predict clinical and histopathological findings, facilitate subgroup identification, and support tailored, individualized surgical strategies. Preoperative work‐up
Erik Kjæstad, Espen Thiis‐Evensen, Anita Sveen, Arne Olav Bakka, Johannes Kurt Schultz   +4 more
wiley   +1 more source

Oncological and Reproductive Outcomes after Fertility-Sparing Surgery in Patients with Advanced-Stage Serous Borderline Ovarian Tumor: A Single-Center Retrospective Study. [PDF]

J Clin Med, 2023
Cang W, Liang C, Wang D, Xue X, Cao D, Yang J, Pan L, Wu M, Yang J, Xiang Y.   +9 more
europepmc   +1 more source

Experiences of Women and Clinicians During the Introduction of Uterine Transplantation to the UK: A Qualitative Case Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To explore the experiences of women and clinicians during the introduction of uterine transplantation (UTx) to the UK. Design A qualitative study utilising prospective case study methodology (interviews and observations) over 6 years.
Daisy Elliott, Richard J. Smith, Maeve Coyle, Rhiannon Macefield, Saliha Vali, Anni King, Natalie Blencowe, Cynthia Ochieng, Christin Hoffmann, Isabel Quiroga, Ben P. Jones, Ariadne L'Heveder, Kerry N. L. Avery, Jane M. Blazeby   +13 more
wiley   +1 more source

Predictive features of borderline ovarian tumor recurrence in patients with childbearing potential undergoing conservative treatment. [PDF]

Mol Clin Oncol, 2022
Capozzi VA, Cianci S, Scarpelli E, Monfardini L, Cianciolo A, Barresi G, Ceccaroni M, Sozzi G, Mandato VD, Uccella S, Franchi M, Chinatera V, Berretta R.   +12 more
europepmc   +1 more source